ZEB1 and pancreatic neoplasm: Overexpression of miR-200c increased the sensitivity to gemcitabine in the ZEB1-expressing, resistant pancreatic cancer cell lines Panc1 and MiaPaca (Fig1B and C; Supplementary Fig S1A and Table1).